At HKLife, we are focused on developing new technologies and products that enables us to continue innovation, and serving our customers worldwide with biotechnology. We work with each of our customers in understanding their needs and providing the world technology and product-based solutions. Research and development is a vital part invested in HKLife, to bring resources through means of biotechnology that makes a difference.
HKLife is committed to continuously increasing the strength of its patent portfolio, by investing in biotechnology innovation research and development devoted to advancing molecular diagnostic technology and applications, and its EFADchip technology.
HKLife’s patent portfolio currently includes 60 patent granted applications worldwide. The list of issued patents below does not represent the full scope of protection covered by the HKLife patent portfolio. |